Table 4 Comparison of serum total fatty acids composition in Hepatitis B patients and controls

C - 14: 0

1.11 ± 0.8

2.04 ± 0.6*

C - 16: 0

21.67 ± 5.8

27.95 ± 3.3*

C - 18: 0

14.27 ± 4.9

13.27 ± 5.5

C - 20: 0

0.56 ± 0.9

0.43 ± 0.3

C – 24: 0

0.08 ± 0.2

0.10 ± 0.2

C - 14: 1

0.44 ± 0.8

0.46 ± 0.3

C - 16: 1

2.96 ± 2.0

3.55 ± 0.8

C - 18: 1

20.28 ± 4.4

21.64 ± 4.0

C - 22: 1

1.74 ± 1.3

1.92 ± 0.6

C – 24: 1

0.24 ± 0.6

0.09 ± 0.2

C - 18: 2

26.49 ± 5.0

21.48 ± 3.4*

C - 18: 3

0.90 ± 1.2

0.31 ± 0.3

C - 20: 3

0.90 ± 1.3

0.62 ± 0.3*

C - 20: 4

6.40 ± 1.9

3.72 ± 0.9*

C - 20: 5

1.08 ± 1.4

0.13 ± 0.2*

C - 22: 5

0.40 ± 0.3

0.79 ± 0.5*

C - 22: 6

0.45 ± 0.4

0.41 ± 0.4

PUFA: SFA

1.0

0.6